To demonstrate that RT is a valid alternative to surgery in men under 70 years old with localized prostate cancer. Dose
Conditions
Interventions
clinical stage T1-
2 N0 M0 prostate cancer who were treated with radical RT
Treatment
patients aged ≤
70 years
Sponsors
no
Eligibility
Sex/Gender
Male
Age
51 Years to 70 Years
Inclusion criteria
Inclusion criteria: patients aged ≤ 70 years (median 68, range 51-70) with clinical stage T1-2 N0 M0 prostate cancer who were treated with radical RT between January 1988 and December 2009All patients had refused RP or were ineligible because of counter-indications
Exclusion criteria
Exclusion criteria: not eligibile for surgery because of counter-indications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival 12/12/2009 years | — |
Secondary
| Measure | Time frame |
|---|---|
| toxicity 12/12/2009 RTOG/EORTC score | — |
Countries
Italy
Contacts
Public ContactRita Bellavita
Unaffiliated
Outcome results
None listed